BD

NeuroSense to Host Investor Webinar on September 12, 2023

Retrieved on: 
Wednesday, September 6, 2023
AD, Therapy, ALS, Hearing, RSVP, BD

CAMBRIDGE, Mass., Sept. 6, 2023 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, announced today it will host an investor webinar conference on Tuesday, September 12, 2023 from 8:30 AM to 9:15 AM Eastern Time.

Key Points: 
  • Investors interested in meeting the executive team and hearing NeuroSense's strategy, updates, and upcoming catalysts are invited to register for the webinar event.
  • CAMBRIDGE, Mass., Sept. 6, 2023 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, announced today it will host an investor webinar conference on Tuesday, September 12, 2023 from 8:30 AM to 9:15 AM Eastern Time.
  • With the completion of a successful financing in June 2023, NeuroSense is in a strong financial position with a capital runway beyond the expected readout of topline data from the Phase 2b PARADIGM trial in Q4 2023.
  • Investors interested in attending the event are invited to register here or RSVP via email: [email protected] .

Parker Elects Denise Russell Fleming to its Board of Directors

Retrieved on: 
Tuesday, September 5, 2023
Boeing, Information technology, Marketing, Business, Boeing Defense, Space & Security, Compact Application Solution Language, Security, Motion, BAE Systems, Engineering, Sprint Corporation, Inbox Business Technologies, BAE Systems Inc., Parker Hannifin, NYSE, BD, Management

CLEVELAND, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today announced the election of Denise Russell Fleming to its Board of Directors, effective September 1, 2023.

Key Points: 
  • CLEVELAND, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today announced the election of Denise Russell Fleming to its Board of Directors, effective September 1, 2023.
  • Ms. Fleming is currently Executive Vice President, Technology and Global Services and Chief Information Officer for BD (Becton, Dickinson & Company), one of the world’s leading medical technology companies.
  • Ms. Fleming then became Vice President, Information Technology and Business Partners for Boeing Defense, Space & Security before taking on her current role with BD in 2022.
  • Ms. Fleming has served on multiple boards of directors for nonprofit organizations and educational institutions.

EQS-News: iOmx Therapeutics appoints Dr. Nils Peter Debus as Chief Business Officer

Retrieved on: 
Tuesday, September 5, 2023
Apollon, Myelocyte, Duke University, Business development, Therapy, Neoplasm, Cancer, Doctor of Philosophy, Schering AG, Humboldt University of Berlin, Boehringer Ingelheim, Patent, CBO, Growth, Schering, BD, Fine chemical, Bayer

Martinsried / Munich, Germany, September 5, 2023 - iOmx Therapeutics AG (iOmx), a clinical stage biopharmaceutical company developing cancer therapeutics based on next generation immune checkpoint targets, today announced the appointment of Dr. Nils Peter Debus as Chief Business Officer (CBO) to drive the company’s new stage of growth.

Key Points: 
  • Martinsried / Munich, Germany, September 5, 2023 - iOmx Therapeutics AG (iOmx), a clinical stage biopharmaceutical company developing cancer therapeutics based on next generation immune checkpoint targets, today announced the appointment of Dr. Nils Peter Debus as Chief Business Officer (CBO) to drive the company’s new stage of growth.
  • Dr. Debus is an accomplished life science leader with 27 years of industry experience and an outstanding track record in Business Development & Licensing.
  • Dr. Apollon Papadimitriou, CEO of iOmx, said: “Nils brings us significant strategic business expertise with a proven success in building partnerships and executing transformative collaborations and acquisitions.
  • Dr. Debus is a microbiologist by training and holds a PhD in embryonic stem cell research from Humboldt University (Berlin, Germany).

Valmet to supply key pulp and paper technologies to Naini Papers in India

Retrieved on: 
Thursday, August 31, 2023
Plastic, Food court, Printing, Osakeyhtiö, Neles, Internet, EUR, BD, Nasdaq Helsinki, Kappa, Cooking, Engineering, Paper, EEST, Calcium carbonate, Automation, Pulp and paper industry, Pulp (paper), Valmet

ESPOO, Finland, Aug. 31, 2023 /PRNewswire/ -- Valmet will deliver key technologies, automation and services to Naini Papers' cooking and fiberline rebuild and new specialty paper machine PM 3 at their mill in Kashipur, India. The delivery will increase the mill's capacity and support meeting the market demand of specialty coated paper. The delivery is scheduled for the first quarter 2025. 

Key Points: 
  • "We have been successfully collaborating with Valmet in many projects, including pulp mills, and decided to choose them again for this rebuild expanding our pulp production capacity.
  • The paper produced by the PM 3 can replace plastics in packages," says Pawan Agarwal, Managing Director, Naini Papers Limited.
  • Naini Papers Limited, founded in 1995, is one of the few premier paper manufacturing companies in India.
  • Valmet is a leading global developer and supplier of process technologies, automation and services for the pulp, paper and energy industries.

Susan G. Komen® To Host MORE THAN PINK Walk in New Jersey This Fall

Retrieved on: 
Tuesday, August 29, 2023
Walkers, THAN, Amanda, Breast cancer, Rutgers Cancer Institute of New Jersey, Hackensack Meridian Health, AbbVie, Patient, Research, Susan, ShopRite, BD, Disease, Pharmaceutical industry, Natera

JACKSON, N.J., Aug. 29, 2023 /PRNewswire/ -- Susan G. Komen ®, the world's leading breast cancer organization, today announced it will host a MORE THAN PINK Walk this fall.

Key Points: 
  • JACKSON, N.J., Aug. 29, 2023 /PRNewswire/ -- Susan G. Komen ®, the world's leading breast cancer organization, today announced it will host a MORE THAN PINK Walk this fall.
  • The New Jersey MORE THAN PINK Walk will take place on Saturday, Oct. 7, 2023.
  • The events will raise critical funds that support breast cancer patients, research and patient navigation services to better serve those impacted by the disease.
  • This year's MORE THAN PINK Walk is made possible by the following sponsors: AbbVie, BD, Hackensack Meridian Health, Natera, RWJBarnabas Health Rutgers Cancer Institute of New Jersey, and ShopRite.

Laura Padilla Joins Sapphire as Portfolio Growth’s Newest Partner and Head of Business Development

Retrieved on: 
Tuesday, August 29, 2023
Professional Services, Other Professional Services, Technology, Software, Asset Management, Networks, Consulting, Sapphire Ventures, Business development, Software as a service, Marketing, Global Partners, Head, Airtable, Business, Channel, CXO, Silicon, Hewlett Packard Enterprise, ARR, Engineering, Zoom Video Communications, Zoom, Growth, CIO, Micro ISV, BD, Bank, Sapphire

Sapphire (Sapphire Ventures, LLC), a global software venture capital firm backing companies of consequence, today announced that Laura Padilla has joined Sapphire as Portfolio Growth’s newest partner and Head of Business Development.

Key Points: 
  • Sapphire (Sapphire Ventures, LLC), a global software venture capital firm backing companies of consequence, today announced that Laura Padilla has joined Sapphire as Portfolio Growth’s newest partner and Head of Business Development.
  • In her new role, Laura will provide strategic counsel to Sapphire’s portfolio companies across their business development needs.
  • Previously a Sapphire Growth Advisor , Laura helped advise Sapphire’s portfolio companies on a range of BD and partner strategies and frameworks, Laura now joins Sapphire to help bolster Portfolio Growth’s impact.
  • “I have seen first-hand the power of Sapphire’s Portfolio Growth platform and the various ways it helps accelerate growth for portfolio companies,” said Laura Padilla, Partner and Head of Business Development, Portfolio Growth at Sapphire.

Flash News - OKX Wallet Partners with Neo for Neo APAC Hackathon in Bangalore, India

Retrieved on: 
Friday, August 25, 2023
Web3, Neo, Senior, SAN, BD, OKX, Cryptocurrency

OKX Wallet is excited to partner with Neo, a leading open-source blockchain platform, for the Neo APAC Hackathon in Bangalore, India in a collaboration that aims to empower OKX Web3 users and promote cutting-edge blockchain development.

Key Points: 
  • OKX Wallet is excited to partner with Neo, a leading open-source blockchain platform, for the Neo APAC Hackathon in Bangalore, India in a collaboration that aims to empower OKX Web3 users and promote cutting-edge blockchain development.
  • Founded in 2014, Neo is a community-driven open-source blockchain platform that welcomes developers to explore the smart economy.
  • By helping developers digitize and automate asset management with smart contracts, Neo is committed to enabling a future-optimized digital world.
  • The Neo APAC Hackathon is scheduled for August 26th to 27th at RMZ, ECOWORLD, Bangalore, with a range of exciting prizes in-store for the winners.

BD to Present at Investor Healthcare Conferences

Retrieved on: 
Wednesday, August 23, 2023
Becton, Dickinson and Company headquarters, Becton, BDX, NYSE, BD, Pharmaceutical industry, Computer data storage

FRANKLIN LAKES, N.J., Aug. 23, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following healthcare conferences:

Key Points: 
  • FRANKLIN LAKES, N.J., Aug. 23, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following healthcare conferences:
    The live webcasts of BD's presentations can be accessed from the BD investor relations website, investors.bd.com .
  • A replay of the events will be available on the same webpage following its conclusion.

IntelliGuard Appoints Robert Howard as CEO and Thomas Koning as President to Execute on Strategy of Continued Growth

Retrieved on: 
Wednesday, August 23, 2023
Hardware, FDA, Manufacturing, Technology, Oncology, Managed Care, Medical Devices, Hospitals, Clinical Trials, Cardiology, Other Manufacturing, Software, Nursing, Health, Medical Supplies, RFID, Intelligence, Multimedia, CCO, Automation, Patient safety, Growth, BD (company), Safety, BD, Management

IntelliGuard , provider of medication and inventory management solutions, today announces the appointments of Robert Howard as Chief Executive Officer (CEO) and Thomas Koning as President.

Key Points: 
  • IntelliGuard , provider of medication and inventory management solutions, today announces the appointments of Robert Howard as Chief Executive Officer (CEO) and Thomas Koning as President.
  • View the full release here: https://www.businesswire.com/news/home/20230823477110/en/
    IntelliGuard Chief Executive Officer Robert Howard (Photo: Business Wire)
    Howard joined IntelliGuard in September 2022 as a member of the Board of Directors.
  • As CEO, he will facilitate interactions and key operative decisions between the Board of Directors and the IntelliGuard leadership team.
  • He served as Vice President of Sales for Europe and North America at Becton, Dickinson and Company (BD), prior to joining IntelliGuard.

SEIA Announces New In-House Broker-Dealer: Signature Estate Securities

Retrieved on: 
Tuesday, August 15, 2023
LOS, SES, SEIA, Partnership, TAMP, Broker-dealer, Alliance Royale, Amerindo Investment Advisors, BD, Financial adviser

LOS ANGELES, Aug. 15, 2023 /PRNewswire/ -- Signature Estate & Investment Advisors (SEIA) today announced the launch of its in-house broker-dealer, Signature Estate Securities (SES). SES acquired a shell broker-dealer and has been preparing and customizing the BD to expand its offering for SEIA advisors. 

Key Points: 
  • Signature Estate Securities will elevate advisors' ability to offer personalized client services.
  • LOS ANGELES, Aug. 15, 2023 /PRNewswire/ -- Signature Estate & Investment Advisors (SEIA) today announced the launch of its in-house broker-dealer, Signature Estate Securities (SES).
  • SES acquired a shell broker-dealer and has been preparing and customizing the BD to expand its offering for SEIA advisors.
  • Signature Estate & Investment Advisors (SEIA) today announced the launch of its in-house broker-dealer, Signature Estate Securities (SES).